SCHEMBL2176369

SCHEMBL2176369

C[C@@](O)(C(=O)N1CCCC1C(=O)Nc1ccc(-c2ccc(-c3ccc(NC(=O)C4CCCN4C(=O)[C@@](C)(O)c4ccccc4)cc3)o2)cc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.50
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
EP300 Q09472 2/20 0.48
CREBBP Q92793 2/20 0.48
KCNH2 Q12809 1/20 0.48
ALDH1A1 P00352 3/20 0.48
MAPK1 P28482 2/20 0.48
HTT P42858 1/20 0.48
LMNA P02545 2/20 0.47
NPC1 O15118 1/20 0.46
PABPC1 P11940 1/20 0.46
NPSR1 Q6W5P4 2/20 0.44
KDM4E B2RXH2 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12491697 1.00 F2 (0.50) F2CYP2C9CYP2C19EP300CREBBP
SCHEMBL14647983 1.00 F2 (0.50) F2CYP2C9CYP2C19EP300CREBBP
SCHEMBL13571817 1.00 F2 (0.50) F2CYP2C9CYP2C19EP300CREBBP
SCHEMBL2176361 1.00 F2 (0.50) F2CYP2C9CYP2C19EP300CREBBP
SCHEMBL14723789 0.93 KCNH2 (0.55) F2CYP2C9CYP2C19EP300CREBBP
SCHEMBL13571431 0.89 ALDH1A1 (0.50) F2CYP2C9CYP2C19EP300CREBBP
SCHEMBL12487606 0.89 ALDH1A1 (0.46) F2CYP2C9CYP2C19EP300CREBBP
SCHEMBL2194014 0.89 ALDH1A1 (0.46) F2CYP2C9CYP2C19EP300CREBBP
SCHEMBL2194019 0.89 ALDH1A1 (0.46) F2CYP2C9CYP2C19EP300CREBBP
SCHEMBL845452 0.85 F2 (0.52) F2CYP2C9CYP2C19EP300CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519506-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-11-07 EP claimed
WO-2011082077-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-07-07 WO claimed